Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients

Completed

Conditions studied: Multiple Myeloma

In brief

An observational study in evaluating the clinical impact of procalcitonin on the care of Stem cell transplant recipient and its performance as an adjunct in the diagnosis and prognostication of Infectious processes

Key facts

Study ID

NCT02035189

Run by

University of Arkansas

People needed

100

Starts

2013-10-01

Expected to finish

2014-09-01

Last updated by the study team

2015-03-03

Who can join

Age: 18 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients age 18-95 years with Multiple Myeloma (MM) undergoing stem cell transplantation

You may not qualify if…

• None

Where it is running

• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.